mConsent to Resell iCoreRx Cloud ePrescribing Solution by iCoreConnect

Strategic Partnership Enhances Patient Engagement Platform with Advanced iCoreRx ePrescribing Software

OCOEE, FL, Aug. 05, 2024 (GLOBE NEWSWIRE) -- iCoreConnect Inc. (NASDAQ: ICCT) (“iCore” or the “Company”), a leading cloud-based software and technology company, today announced a new reseller agreement with mConsent, a leader in digital patient intake, patient communication and engagement solutions. Through this partnership, mConsent will now offer iCoreConnect's premier electronic prescribing software, iCoreRx, as part of its suite of digital solutions.